Home > National Drug Code (NDC) > Treatment Set TS339992

Treatment Set TS339992 - 49288-0804-3 - (Treatment Set TS339992)

Alphabetical Index


Drug Information of Treatment Set TS339992

Product NDC: 49288-0804
Proprietary Name: Treatment Set TS339992
Non Proprietary Name: Treatment Set TS339992
Active Ingredient(s): .005; 10000; 1000; 400; 400; .005; .002; 4000; .005    g/mL; [AU]/mL; [BAU]/mL; [AU]/mL; [AU]/mL; g/mL; g/mL; [BAU]/mL; g/mL & nbsp;   Treatment Set TS339992
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS339992

Product NDC: 49288-0804
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS339992

Package NDC: 49288-0804-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0804-3)

NDC Information of Treatment Set TS339992

NDC Code 49288-0804-3
Proprietary Name Treatment Set TS339992
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0804-3)
Product NDC 49288-0804
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS339992
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER NEGUNDO POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; IVA ANNUA VAR. ANNUA POLLEN; JUNIPERUS ASHEI POLLEN; PHLEUM PRATENSE POLLEN; ULMUS AMERICANA POLLEN
Strength Number .005; 10000; 1000; 400; 400; .005; .002; 4000; .005
Strength Unit g/mL; [AU]/mL; [BAU]/mL; [AU]/mL; [AU]/mL; g/mL; g/mL; [BAU]/mL; g/mL
Pharmaceutical Classes Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS339992


General Information